Cellebrite DI Ltd. (NASDAQ:CLBT) has received a broker consensus recommendation of “Moderate Buy.”
According to Bloomberg.com, the seven research firms currently covering the stock have rated "Moderate Buy" as their consensus recommendation for ...
Tag: CLBT, Analyst Rating
Cellebrite DI (CLBT) will report earnings on Wednesday.
On February 15, before the market's opening, Cellebrite DI (NASDAQ: CLBT) will release the quarterly results report that it has ...
Short interest in Cellebrite DI Ltd. (NASDAQ:CLBT) has increased significantly.
There was a discernible increase in the number of short positions taken on Cellebrite DI Ltd. during December (NASDAQ: CLBT). ...